Page last updated: 2024-08-24

3-iodobenzylguanidine and 19-iodocholesterol

3-iodobenzylguanidine has been researched along with 19-iodocholesterol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Francis, I; Glazer, GM; Gross, MD; Khafagi, FA; Shapiro, B; Thompson, NW1
Fischer, M; Vetter, H1
Levasseur, A; Picard, D; Taillefer, R1
Sisson, JC1
Klain, M; Mainolfi, C; Maurea, S; Salvatore, M; Ziviello, M1
Lawson, MA1
Caraco, C; Klain, M; Maurea, S; Salvatore, M; Ziviello, M1
Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M1
Tenenbaum, F1

Reviews

2 review(s) available for 3-iodobenzylguanidine and 19-iodocholesterol

ArticleYear
[Scintigraphic studies of the adrenal and parathyroid glands].
    L'union medicale du Canada, 1986, Volume: 115, Issue:4

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adosterol; Adrenal Gland Diseases; Cushing Syndrome; Humans; Hyperaldosteronism; Hyperparathyroidism; Iodobenzenes; Parathyroid Diseases; Radioisotopes; Radionuclide Imaging; Thallium

1986
[Adrenal incidentaloma and nuclear medicine examination].
    Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 2

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals

2009

Trials

1 trial(s) available for 3-iodobenzylguanidine and 19-iodocholesterol

ArticleYear
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2004

Other Studies

6 other study(ies) available for 3-iodobenzylguanidine and 19-iodocholesterol

ArticleYear
Clinical significance of the large adrenal mass.
    The British journal of surgery, 1991, Volume: 78, Issue:7

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed

1991
[Adrenal gland scintigraphy].
    Der Radiologe, 1986, Volume: 26, Issue:4

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Cholesterol; Cushing Syndrome; Dexamethasone; Humans; Hyperaldosteronism; Iodobenzenes; Pheochromocytoma; Radionuclide Imaging; Selenium; Succimer; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid

1986
Radiopharmaceuticals for nuclear endocrinology at the University of Michigan.
    Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:4

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Animals; Endocrine System Diseases; History, 20th Century; Humans; Michigan; Nuclear Medicine; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Universities

2000
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:6

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity

2001
Role of molecular imaging in management of nonhypersecreting adrenal masses.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:6

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity

2001
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
    Nuclear medicine communications, 2002, Volume: 23, Issue:10

    Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2002